Suppression of Corticosteroid-Induced Ocular Hypertension in Sheep by Anecortave
Authors:
- Oscar A. CandiaOCOscar A. Candia
- Rosana GeromettaRGRosana Gerometta
- J. Cameron MillarJMJ. Cameron Millar
- Steven M. PodosSPSteven M. Podos
Open Access
- 1 March 2010
- journal article
- laboratory sciences
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 128 (3) , 338-343
Abstract
Anecortave acetate (15-mg anecortave acetate suspension; Alcon Laboratories, Fort Worth, Texas) is an angiostatic steroid that is synthesized from cortisol acetate.1 This cortisene is devoid of conventional corticosteroid hormone activity but is an effective inhibitor of neovascularization in several models for experimental angiogenesis.1,2 It has also been administered, with encouraging results, to patients with diabetic retinopathy and age-related macular degeneration in an effort to treat the angiogenic complications of these diseases.2-4Keywords
This publication has 20 references indexed in Scilit:
- Reduction of Intraocular Pressure With Anecortave Acetate in Eyes With Ocular Steroid Injection–Related GlaucomaArchives of Ophthalmology (1950), 2009
- Steroid-Induced Ocular Hypertension in Normal SheepInvestigative Ophthalmology & Visual Science, 2009
- Anterior Juxtascleral Delivery of Anecortave Acetate in Eyes with Primary Open-Angle Glaucoma: A Pilot InvestigationAmerican Journal of Ophthalmology, 2008
- Emerging Therapies for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaBioDrugs, 2007
- Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration—A Review of Clinical OutcomesSurvey of Ophthalmology, 2007
- Mechanism of Action of the Angiostatic Cortisene Anecortave AcetateSurvey of Ophthalmology, 2007
- Corticosteroid-induced glaucoma: a review of the literatureEye, 2005
- Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataractOphthalmology, 2005
- Ocular Hypotensive and Aqueous Outflow-enhancing Effects of AL-3037A (Sodium Ferri Ethylenediaminetetraacetate)Experimental Eye Research, 2001
- AL-3789: a novel ophthalmic angiostatic steroidExpert Opinion on Investigational Drugs, 1997